Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'BONE-MARROW FAILURE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 95 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Yamashita, T; Nakahata, T
      Current knowledge on the pathophysiology of Fanconi anemia: From genes to phenotypes

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    2. Tarcan, A; Ozbek, N; Gurakan, B
      Bone marrow failure with concurrent enteroviral infection in a newborn

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    3. Kaptan, K; Beyan, C; Ural, AU; Ustun, C; Cetin, T; Avcu, F; Kubar, A; Alis, M; Yalcin, A
      Successful treatment of severe aplastic anemia associated with human parvovirus B19 and Epstein-Barr virus in a healthy subject with Allo-BMT

      AMERICAN JOURNAL OF HEMATOLOGY
    4. Anjaria, DJ; Rameshwar, P; Deitch, EA; Xu, DZ; Adams, CA; Forsythe, RM; Sambol, JT; Hauser, CJ; Livingston, DH
      Hematopoietic failure after hemorrhagic shock is mediated partially through mesenteric lymph

      CRITICAL CARE MEDICINE
    5. Luther-Wyrsch, A; Nissen, C; Wodnar-Filipowicz, A
      Intracellular Fas ligand is elevated in T lymphocytes in severe aplastic anaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    6. Dror, Y; Ginzberg, H; Dalal, I; Cherepanov, V; Downey, G; Durie, P; Roifman, CM; Freedman, MH
      Immune function in patients with Shwachman-Diamond syndrome

      BRITISH JOURNAL OF HAEMATOLOGY
    7. Dokal, I
      The genetics of Fanconi's anaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    8. Yokoyama, M; Suto, Y; Sato, H; Arai, K; Waga, S; Kitazawa, J; Maruyama, H; Ito, E
      Low serum lipids suggest severe bone marrow failure in children with aplastic anemia

      PEDIATRICS INTERNATIONAL
    9. Millar, MM; Grammer, LC
      Case reports of evaluation and desensitization for anti-thymocyte globulinhypersensitivity

      ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
    10. Marta, RF; Enria, D; Molinas, FC
      Relationship between hematopoietic growth factors levels and hematologicalparameters in argentine hemorrhagic fever

      AMERICAN JOURNAL OF HEMATOLOGY
    11. Simon, A; Bindl, L; Kramer, MH
      Surveillance of nosocomial infections: Prospective study in a pediatric intensive care unit

      KLINISCHE PADIATRIE
    12. Barrett, J; Saunthararajah, Y; Molldrem, J
      Myelodysplastic syndrome and aplastic anemia: Distinct entities or diseases linked by a common pathophysiology?

      SEMINARS IN HEMATOLOGY
    13. Sieff, CA; Nisbet-Brown, E; Nathan, DG
      Congenital bone marrow failure syndromes

      BRITISH JOURNAL OF HAEMATOLOGY
    14. Dokal, I
      Dyskeratosis congenita in all its forms

      BRITISH JOURNAL OF HAEMATOLOGY
    15. Pfister, O; Chklovskaia, E; Jansen, W; Meszaros, K; Nissen, C; Rahner, C; Hurwitz, N; Bogatcheva, N; Lyman, SD; Wodnar-Filipowicz, A
      Chronic overexpression of membrane-bound flt3 ligand by T lymphocytes in severe aplastic anaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    16. Huber, PAJ; Medhurst, AL; Youssoufian, H; Mathew, CG
      Investigation of Fanconi anemia protein interactions by yeast two-hybrid analysis

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    17. Borkowski, J; Amrikachi, M; Hudnall, SD
      Fulminant parvovirus infection following erythropoietin treatment in a patient with acquired immunodeficiency syndrome

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    18. Mangi, MH; Newland, AC
      Interleukin-3 in hematology and oncology: Current state of knowledge and future directions

      CYTOKINES CELLULAR & MOLECULAR THERAPY
    19. Gluckman, E; Rocha, V; Chastang, C
      Cord blood stem cell transplantation

      BAILLIERES CLINICAL HAEMATOLOGY
    20. Novitzky, N; Jacobs, P
      In aplastic anemia progenitor cells have a reduced sensitivity to the effects of growth factors

      EUROPEAN JOURNAL OF HAEMATOLOGY
    21. Yu, JM; Emmons, RVB; Hanazono, Y; Sellers, S; Young, NS; Dunbar, CE
      Expression of interferon-gamma by stromal cells inhibits murine long-term repopulating hematopoietic stem cell activity

      EXPERIMENTAL HEMATOLOGY
    22. LEVRAN O; DOGGETT NA; AUERBACH AD
      IDENTIFICATION OF ALU-MEDIATED DELETIONS IN THE FANCONI-ANEMIA GENE FAA

      Human mutation
    23. NAIDES SJ
      RHEUMATIC MANIFESTATIONS OF PARVOVIRUS B19 INFECTION

      Rheumatic diseases clinics of North America
    24. SOUILLET G
      INDICATIONS AND RESULTS OF PROGENITOR-CELL TRANSPLANT IN CONGENITAL HEMOPATHIES (EXCEPT FANCONI-ANEMIA)

      Bone marrow transplantation
    25. Yamada, H; Kato, EH; Furuta, I; Hoshi, N; Koizumi, K; Sawada, K; Fujimoto, S
      Hematopoietic cytokine levels and in vitro colony formation assay in fetalanemia

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    26. GRAY A; GUILLOU L; ZUFFEREY J; REY F; KURT AM; JICHLINSKI P; LEISINGER HJ; BENHATTAR J
      PERSISTENCE OF PARVOVIRUS B19 DNA IN TESTIS OF PATIENTS WITH TESTICULAR GERM-CELL TUMORS

      Journal of General Virology
    27. BALKHY HH; SABELLA C; GOLDFARB J
      PARVOVIRUS - A REVIEW

      Bulletin on rheumatic diseases
    28. TAYLOR DS; LEE Y; SIEFF CA; HOMANS A; GARRISON L; GUINAN EC
      PHASE I II TRIAL OF PIXY321 (GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR INTERLEUKIN-3 FUSION PROTEIN) FOR TREATMENT OF INHERITED AND ACQUIRED MARROW FAILURE SYNDROMES/

      British Journal of Haematology
    29. COULTHARD S; CHASE A; PICKARD J; GOLDMAN J; DOKAL I
      CHROMOSOMAL BREAKAGE ANALYSIS IN DYSKERATOSIS-CONGENITA PERIPHERAL-BLOOD LYMPHOCYTES

      British Journal of Haematology
    30. Knight, S; Vulliamy, T; Copplestone, A; Gluckman, E; Mason, P; Dokal, I
      Dyskeratosis Congenita (DC) Registry: identification of new features of DC

      BRITISH JOURNAL OF HAEMATOLOGY
    31. DIERDORF R; KREUTER U; JONES TC
      USE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN THE TREATMENT OF PROLONGED HEMATOPOIETIC DYSFUNCTION AFTER CHEMOTHERAPY ALONE ORCHEMOTHERAPY PLUS BONE-MARROW TRANSPLANTATION

      Medical oncology
    32. KONDO H; DATE Y
      BENEFIT OF SIMULTANEOUS RHG-CSF AND METHYLPREDNISOLONE PULSE THERAPY FOR METHOTREXATE-INDUCED BONE-MARROW FAILURE IN RHEUMATOID-ARTHRITIS

      International journal of hematology
    33. HOVGAARD DJ; SKOV PS; NISSEN NI
      THE IN-VIVO EFFECTS OF INTERLEUKIN-3 ON HISTAMINE LEVELS IN NON-HODGKINS-LYMPHOMA PATIENTS

      Pharmacology & toxicology
    34. EBENBICHLER CF; WURZNER R; SANDHOFER AD; NIEDERWIESER D; DIERICH MP; PATSCH JR
      ANTI-THYMOCYTE GLOBULIN TREATMENT OF A PATIENT FOR PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA-APLASTIC ANEMIA SYNDROME - COMPLEMENT ACTIVATION ANDTRANSIENT DECREASE OF THE PNH CLONE

      Immunobiology
    35. DOKAL I; RULE S; CHEN F; POTTER M; GOLDMAN J
      ADULT-ONSET OF ACUTE MYELOID-LEUKEMIA (M6) IN PATIENTS WITH SHWACHMAN-DIAMOND-SYNDROME

      British Journal of Haematology
    36. QAZILBASH MH; LIU JM; VLACHOS A; FRUCHTMAN S; MESSNER H; ZIPURSKY A; ALTER BP; YOUNG NS
      A NEW SYNDROME OF FAMILIAL APLASTIC-ANEMIA AND CHRONIC LIVER-DISEASE

      Acta haematologica
    37. BUKOWSKI RM; OLENCKI T; GUNN H; MCLAIN D; BUDD GT; SANDSTROM K; TUASON L; REDOVAN C; RAYMAN P; TUBBS R; RESTA D; ELSON P; FINKE J
      PHASE-I TRIAL OF SUBCUTANEOUS INTERLEUKIN-3 IN PATIENTS WITH REFRACTORY MALIGNANCY - HEMATOLOGICAL, IMMUNOLOGICAL, AND PHARMACODYNAMIC FINDINGS

      Clinical cancer research
    38. HIGUCHI T; MORI H; NIIKURA H; OMINE M; FUJITA K
      PROGNOSTIC IMPLICATIONS IN MYELODYSPLASTIC SYNDROMES - A REVIEW OF 62CASES

      Leukemia & lymphoma
    39. HURWITZ N; PROBST A; ZUFFEREY G; TICHELLI A; PLESS M; KAPPOS L; SPECK B; GRATWOHL A
      FATAL VASCULAR LEAK SYNDROME WITH EXTENSIVE HEMORRHAGE, PERIPHERAL NEUROPATHY AND REACTIVE ERYTHROPHAGOCYTOSIS - AN UNUSUAL COMPLICATION OFRECOMBINANT IL-3 THERAPY

      Leukemia & lymphoma
    40. YOUNG NS
      IMMUNE PATHOPHYSIOLOGY OF ACQUIRED APLASTIC-ANEMIA

      European journal of haematology
    41. MANZ CY; NISSEN C; WODNARFILIPOWICZ A
      DEFICIENCY OF CD34(-KIT(+) AND CD34(+)38(-) HEMATOPOIETIC PRECURSORS IN APLASTIC-ANEMIA AFTER IMMUNOSUPPRESSIVE TREATMENT()C)

      American journal of hematology
    42. KUDOH S; SAWA T; KURIHARA N; FURUSE K; KURITA Y; FUKUOKA M; TAKADA M; TAKAKU F; OGAWA M; ARIYOSHI Y
      PHASE-II STUDY OF RECOMBINANT HUMAN INTERLEUKIN-3 ADMINISTRATION FOLLOWING CARBOPLATIN AND ETOPOSIDE CHEMOTHERAPY IN SMALL-CELL LUNG-CANCERPATIENTS

      Cancer chemotherapy and pharmacology
    43. SOLDER B; WEISS M; JAGER A; BELOHRADSKY BH
      DYSKERATOSIS-CONGENITA - AN INHERITED, HE MATOLOGICAL-IMMUNOLOGICAL DISEASE-ASSOCIATED WITH PANCYTOPENIA

      Klinische Padiatrie
    44. DUNN DE; YU J; NAGARAJAN S; DEVETTEN M; WEICHOLD FF; MEDOF ME; YOUNG NS; LIU JM
      A KNOCK-OUT MODEL OF PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA - PIG-A(-) HEMATOPOIESIS IS RECONSTITUTED FOLLOWING INTERCELLULAR TRANSFER OF GPI-ANCHORED PROTEINS

      Proceedings of the National Academy of Sciences of the United Statesof America
    45. YOUNES A; SARRIS A; CONSOLI U; RODRIGUEZ A; MCLAUGHLIN P; HUH Y; STARRY S; CABANILLAS F; ANDREEFF M
      A PILOT-STUDY OF HIGH-DOSE INTERLEUKIN-3 TREATMENT OF RELAPSED FOLLICULAR SMALL CLEAVED-CELL LYMPHOMA - HEMATOLOGIC, IMMUNOLOGICAL, AND CLINICAL-RESULTS

      Blood
    46. SOCIE G; BACIGALUPO A; DEVERGIE A; CAROSELLA E; GLUCKMAN E
      ACQUIRED APLASTIC-ANEMIA - OPTIMUM IMMUNOSUPPRESSIVE TREATMENT

      CLINICAL IMMUNOTHERAPEUTICS
    47. RINEHART J; MARGOLIN KA; TRIOZZI P; HERSH E; CAMPION M; RESTA D; LEVITT D
      PHASE-I TRIAL OF RECOMBINANT INTERLEUKIN-3 BEFORE AND AFTER CARBOPLATIN ETOPOSIDE CHEMOTHERAPY IN PATIENTS WITH SOLID TUMORS - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Clinical cancer research
    48. ROSOFF PM
      CONGENITAL BONE-MARROW FAILURE WITH MYELODYSPLASIA IN SIBLINGS

      Journal of pediatric hematology/oncology
    49. BORDIGONI P
      BONE-MARROW TRANSPLANTATION FOR INHERITED BONE-MARROW FAILURE SYNDROMES

      International journal of pediatric hematology/oncology
    50. WAGEMAKER G
      HETEROGENEITY OF RADIATION SENSITIVITY OF HEMATOPOIETIC STEM-CELL SUBSETS

      Stem cells
    51. GARCIATAPIA AM; DELALAMO CFG; GIRON JA; MIRA J; DELARUBIA F; MARTINEZRODRIGUEZ A; MARTINREINA MV; LOPEZCAPARROS R; CALIZ R; CABALLERO MS; BASCUNANA A
      SPECTRUM OF PARVOVIRUS B19 INFECTION - ANALYSIS OF AN OUTBREAK OF 43 CASES IN CADIZ, SPAIN

      Clinical infectious diseases
    52. JOENJE H; MATHEW C; GLUCKMAN E
      FANCONI-ANEMIA RESEARCH - CURRENT STATUS AND PROSPECTS

      European journal of cancer
    53. HOVGAARD DJ; NISSEN NI
      EFFECTS OF INTERLEUKIN-3 FOLLOWING CHEMOTHERAPY OF NON-HODGKINS-LYMPHOMA - A PROSPECTIVE, CONTROLLED PHASE I II STUDY/

      European journal of haematology
    54. SCADDEN DT; LEVINE JD; BRESNAHAN J; GERE J; MCGRATH J; WANG ZY; RESTA DJ; YOUNG D; HAMMER SM
      IN-VIVO EFFECTS OF INTERLEUKIN-3 IN HIV TYPE 1-INFECTED PATIENTS WITHCYTOPENIA

      AIDS research and human retroviruses
    55. VERBEEK W; VEHMEYER K; WORMANN B; HIDDEMANN W
      THE EFFECT OF STEM-CELL FACTOR, INTERLEUKIN-3 AND ERYTHROPOIETIN ON IN-VITRO ERYTHROPOIESIS IN MYELODYSPLASTIC SYNDROMES

      Journal of cancer research and clinical oncology
    56. YAVORKOVSKY LI
      PARVOVIRUS B19 (PV-B19) AND HUMAN-DISEASE S

      Terapevticeskij arhiv
    57. MEUSSER S; BECK R; FLECKENSTEIN B; KALDEN JR
      25-YEAR-OLD PATIENT WITH PANCYTOPENIA - S EVERE APLASTIC-ANEMIA IN PARVOVIRUS B19 INFECTION

      Der Internist
    58. HUHN RD; YURKOW EJ; KUHN JG; CLARKE L; GUNN H; RESTA D; SHAH R; MYERS LA; SEIBOLD JR
      PHARMACODYNAMICS OF DAILY SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-3 IN NORMAL VOLUNTEERS

      Clinical pharmacology and therapeutics
    59. TARANTINO MD; SHAHIDI NT
      PARVOVIRUS B19-INDUCED RED-BLOOD-CELL APLASIA COMPLICATING IRON-DEFICIENCY ANEMIA

      Clinical pediatrics
    60. BARGETZI MJ; GLUCKMAN E; TICHELLI A; DEVERGIE A; ESPEROU H; KABATA J; WODNARFILIPOWICZ A; NISSEN C; SPECK B; GRATWOHL A
      RECOMBINANT HUMAN INTERLEUKIN-3 IN REFRACTORY SEVERE APLASTIC-ANEMIA - A PHASE I II TRIAL/

      British Journal of Haematology
    61. HOVGAARD DJ; MORTENSEN BT; NISSEN NI
      PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES OF SUBCUTANEOUSLY ADMINISTERED RECOMBINANT HUMAN INTERLEUKIN-3 FOLLOWING CHEMOTHERAPY FOR NON-HODGKINS-LYMPHOMA

      British Journal of Haematology
    62. VADHANRAJ S; BROXMEYER HE; ANDREEFF M; BANDRES JC; BUESCHER ES; BENJAMIN RS; PAPADOPOULOS NE; BURGESS A; PATEL S; PLAGER C; HITTELMAN WN; MCALISTER I; GARRISON L; WILLIAMS DE
      IN-VIVO BIOLOGIC EFFECTS OF PIXY321, A SYNTHETIC HYBRID PROTEIN OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND INTERLEUKIN-3 IN CANCER-PATIENTS WITH NORMAL HEMATOPOIESIS - A PHASE-I STUDY

      Blood
    63. VANGILS FCJM; VANTEEFFELEN MEJM; NEELIS KJ; HENDRIKX J; BURGER H; VANLEEN RW; KNOL E; WAGEMAKER G; WOGNUM AW
      INTERLEUKIN-3 TREATMENT OF RHESUS-MONKEYS LEADS TO INCREASED PRODUCTION OF HISTAMINE-RELEASING CELLS THAT EXPRESS INTERLEUKIN-3 RECEPTORS AT HIGH-LEVELS

      Blood
    64. VADHANRAJ S
      PIXY321 (GM-CSF IL-3 FUSION PROTEIN) - BIOLOGY AND EARLY CLINICAL DEVELOPMENT

      Stem cells
    65. SEIPELT G; GANSER A; DURANCEYK H; MAURER A; OTTMANN OG; HOELZER D
      INDUCTION OF SOLUBLE IL-2 RECEPTOR IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES UNDERGOING HIGH-DOSE INTERLEUKIN-3 TREATMENT

      Annals of hematology
    66. TANG MLK; KEMP AS; MOAVEN LD
      PARVOVIRUS B19-ASSOCIATED RED-BLOOD-CELL APLASIA IN COMBINED IMMUNODEFICIENCY WITH NORMAL IMMUNOGLOBULINS

      The Pediatric infectious disease journal
    67. NIMER SD; PAQUETTE RL; IRELAND P; RESTA D; YOUNG D; GOLDE DW
      A PHASE I II STUDY OF INTERLEUKIN-3 IN PATIENTS WITH APLASTIC-ANEMIA AND MYELODYSPLASIA/

      Experimental hematology
    68. MURRAY JC; KELLEY PK; HOGREFE WR; MCCLAIN KL
      CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA - ASSOCIATION WITH HUMAN PARVOVIRUS B19 INFECTION

      The American journal of pediatric hematology/oncology
    69. STONE RM; BERNSTEIN SH; DEMETRI G; FACKLAM DP; ARTHUR K; ANDERSEN J; ASTER JC; KUFE D
      THERAPY WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

      Leukemia research
    70. MURPHY WG; PALMER JP; GREEN RHA
      THE MANAGEMENT OF HEMORRHAGE IN THE REFRACTORY NON-ALLOIMMUNIZED THROMBOCYTOPENIC PATIENT

      Vox sanguinis
    71. AULITZKY WE; SCHULER M; PESCHEL C; HUBER C
      INTERLEUKINS - CLINICAL-PHARMACOLOGY AND THERAPEUTIC USE

      Drugs
    72. TEPLER I; ELIAS A; KALISH L; SHULMAN L; STRAUSS G; SKARIN A; LYNCH T; LEVITT D; RESTA D; DEMETRI G; GAYNES L; SCHNIPPER L
      EFFECT OF RECOMBINANT HUMAN INTERLEUKIN-3 ON HEMATOLOGICAL RECOVERY FROM CHEMOTHERAPY-INDUCED MYELOSUPPRESSION

      British Journal of Haematology
    73. HOVGAARD DJ; FOLKE M; MORTENSEN BT; NISSEN NI
      RECOMBINANT HUMAN INTERLEUKIN-3 - PHARMACOKINETICS AFTER INTRAVENOUS AND SUBCUTANEOUS BOLUS INJECTION AND EFFECTS ON GRANULOCYTE KINETICS

      British Journal of Haematology
    74. MACIEJEWSKI JP; ANDERSON S; KATEVAS P; YOUNG NS
      PHENOTYPIC AND FUNCTIONAL-ANALYSIS OF BONE-MARROW PROGENITOR-CELL COMPARTMENT IN BONE-MARROW FAILURE

      British Journal of Haematology
    75. GANSER A; OTTMANN OG; HOELZER D
      INTERLEUKIN-3 AND INTERLEUKIN-3 GM-CSF COMBINATION THERAPY - CLINICALIMPLICATIONS/

      Stem cells
    76. GUILLAUME T; DHONDT V; SYMANN M
      IL-3 AND PERIPHERAL-BLOOD STEM-CELL HARVESTING

      Stem cells
    77. AGLIETTA M; PASQUINO P; SANAVIO F; STACCHINI A; SEVERINO A; FUBINI L; MORELLI S; VOLTA C; MONTEVERDE A; PIACIBELLO W; GAVOSTO F
      GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND INTERLEUKIN-3 - TARGET-CELLS AND KINETICS OF RESPONSE IN-VIVO

      Stem cells
    78. SIEFF C; GUINAN E
      IN-VITRO ENHANCEMENT OF ERYTHROPOIESIS BY STEEL FACTOR IN DIAMOND-BLACKFAN ANEMIA AND TREATMENT OF OTHER CONGENITAL CYTOPENIAS WITH RECOMBINANT INTERLEUKIN-3 GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR/

      Stem cells
    79. GILLIO AP; FAULKNER LB; ALTER BP; REILLY L; KLAFTER R; HELLER G; YOUNG DC; LIPTON JM; MOORE MAS; OREILLY RJ
      SUCCESSFUL TREATMENT OF DIAMOND-BLACKFAN ANEMIA WITH INTERLEUKIN-3

      Stem cells
    80. RAEMAEKERS JMM; VANIMHOFF GW; VERDONCK LF; HESSELS JA; FIBBE WE
      THE TOLERABILITY OF CONTINUOUS INTRAVENOUS-INFUSION OF INTERLEUKIN-3 AFTER DHAP CHEMOTHERAPY IN PATIENTS WITH RELAPSED MALIGNANT-LYMPHOMA -A PHASE-I STUDY

      Annals of hematology
    81. GIANNI AM; SIENA S; BREGNI M; DINICOLA M; PECCATORI F; MAGNI M; RAVAGNANI F; SKLENAR I; BONADONNA G
      RECOMBINANT HUMAN INTERLEUKIN-3 HASTENS TRILINEAGE HEMATOPOIETIC RECOVERY FOLLOWING HIGH-DOSE (7 G M(2)) CYCLOPHOSPHAMIDE CANCER-THERAPY/

      Annals of oncology
    82. NAIDES SJ
      PARVOVIRUS-B19 INFECTION

      Rheumatic diseases clinics of North America
    83. BUESCHER ES; MCILHERAN SM; BANKS SM; VADHANRAJ S
      THE EFFECTS OF TREATMENT WITH PIXY321 (GM-CSF IL-3 FUSION PROTEIN) ONHUMAN POLYMORPHONUCLEAR LEUKOCYTE FUNCTION/

      Experimental hematology
    84. VALLBRACHT A; FLEISCHER B; BUSCH FW
      HEPATITIS-A - HEPATOTROPISM AND INFLUENCE ON MYELOPOIESIS

      Intervirology
    85. GANSER A; HOELZER D
      THERAPEUTIC VALUE OF INTERLEUKIN-3 GIVEN ALONE OR IN COMBINATION WITHOTHER CYTOKINES

      Nouvelle revue francaise d'hematologie
    86. HELLER HM; BECK WS; DZIECZKOWSKI JS; HARRIS NL; BASGOZ N; UEDA PL
      A 28-YEAR-OLD MAN WITH AIDS, PERSISTENT PANCYTOPENIA, AND LYMPHOMA - PARVOVIRUS B19 INFECTION - LARGE-CELL LYMPHOMA - ACQUIRED-IMMUNODEFICIENCY-SYNDROME

      The New England journal of medicine
    87. GARCIAGONZALEZ M; BOIXEDA D; HERRERO D; BURGALETA C
      EFFECT OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ON LEUKOCYTE FUNCTION IN CIRRHOSIS

      Gastroenterology
    88. BIESMA B; POKORNY R; KOVARIK JM; DUFFY FA; WILLEMSE PHB; MULDER NH; DEVRIES EGE
      PHARMACOKINETICS OF RECOMBINANT HUMAN INTERLEUKIN-3 ADMINISTERED SUBCUTANEOUSLY AND BY CONTINUOUS INTRAVENOUS-INFUSION IN PATIENTS AFTER CHEMOTHERAPY FOR OVARIAN-CANCER

      Cancer research
    89. FREEDMAN MH
      PURE RED-CELL APLASIA IN CHILDHOOD AND ADOLESCENCE - PATHOGENESIS ANDAPPROACHES TO DIAGNOSIS

      British Journal of Haematology
    90. DERCKSEN MW; HOEKMAN K; HUININK WWT; RANKIN EM; DUBBELMAN R; VANTINTEREN H; WAGSTAFF J; PINEDO HM
      EFFECTS OF INTERLEUKIN-3 ON MYELOSUPPRESSION INDUCED BY CHEMOTHERAPY FOR OVARIAN-CANCER AND SMALL-CELL UNDIFFERENTIATED TUMORS

      British Journal of Cancer
    91. AGLIETTA M; SANAVIO F; STACCHINI A; MORELLI S; FUBINI L; SEVERINO A; PASQUINO P; VOLTA C; BRETTI S; TAFUTO S; ZOLA P; SISMONDI P; SKLENAR I; PIACIBELLO W; BUSSOLINO F; GAVOSTO F
      INTERLEUKIN-3 IN-VIVO - KINETIC OF RESPONSE OF TARGET-CELLS

      Blood
    92. GILLIO AP; FAULKNER LB; ALTER BP; REILLY L; KLAFTER R; HELLER G; YOUNG DC; LIPTON JM; MOORE MAS; OREILLY RJ
      TREATMENT OF DIAMOND-BLACKFAN ANEMIA WITH RECOMBINANT HUMAN INTERLEUKIN-3

      Blood
    93. VANGILS FCJM; MULDER AH; VANDENBOS C; BURGER H; VANLEEN RW; WAGEMAKER G
      ACUTE SIDE-EFFECTS OF HOMOLOGOUS INTERLEUKIN-3 IN RHESUS-MONKEYS

      The American journal of pathology
    94. DUNKEL IJ; BUSSEL JB
      NEW DEVELOPMENTS IN THE TREATMENT OF NEUTROPENIA

      American journal of diseases of children [1960]
    95. YOTO Y; KUDOH T; SUZUKI N; MATSUNAGA Y; CHIBA S
      RETROSPECTIVE STUDY ON THE INFLUENCE OF HUMAN PARVOVIRUS B19 INFECTION AMONG CHILDREN WITH MALIGNANT DISEASES

      Acta haematologica


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/05/20 alle ore 10:48:17